Predictive value of interim PET/CT visual interpretation in the prognosis of patients with aggressive non-Hodgkin’s lymphoma

References

• PulteDJansenLGondosAGEKID Cancer Survival Working GroupSurvival of patients with non-Hodgkin lymphoma in Germany in the early 21st centuryLeuk Lymphoma201354597998523098058
   PubMed Web of Science ®Google Scholar
• PhilipTHartmannOBironPHigh-dose therapy and autologous bone marrow transplantation in partial remission after first-line induction therapy for diffuse non-Hodgkin’s lymphomaJ Clin Oncol198867111811243292712
   PubMed Web of Science ®Google Scholar
• International Non-Hodgkin’s Lymphoma Prognostic Factors ProjectA predictive model for aggressive non-Hodgkin’s lymphomaN Engl J Med1993329149879948141877
   PubMed Web of Science ®Google Scholar
• HuangHHXiaoFChenFYReassessment of the prognostic value of the International Prognostic Index and the revised International Prognostic Index in patients with diffuse large B-cell lymphoma: a multicentre studyExp Ther Med20124347548023181121
   PubMedGoogle Scholar
• ChesonBDFisherRIBarringtonSFRecommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classificationJ Clin Oncol201432273059306825113753
   PubMed Web of Science ®Google Scholar
• StewartDAKloiberROwenCResults of a prospective phase II trial evaluating interim positron emission tomography-guided high dose therapy for poor prognosis diffuse large B-cell lymphomaLeuk Lymphoma20145592064207024188476
   PubMed Web of Science ®Google Scholar
• PregnoPChiappellaABelloMInterim 18-FDG-PET/CT failed to predict the outcome in diffuse large B-cell lymphoma patients treated at the diagnosis with rituximab-CHOPBlood201211992066207322234681
   PubMed Web of Science ®Google Scholar
• CasasnovasROMeignanMBerriolo-RiedingerAGroupe d’étude des lymphomes de l’adulte (GELA)SUVmax reduction improves early prognosis value of interim positron emission tomography scans in diffuse large B-cell lymphomaBlood20111181374321518924
   PubMed Web of Science ®Google Scholar
• CoxMCAmbrogiVLanniVUse of interim [F-18]fluorodeoxyglucose-positron emission tomography is not justified in diffuse large B-cell lymphoma during first-line immunochemotherapyLeuk Lymphoma201253226326921846184
   PubMed Web of Science ®Google Scholar
• JaffeESHarrisNLSteinHVardimanJWPathology and Genetics of Tumours of Haematopoietic and Lymphoid TissuesLyonIARC Press2001
   Google Scholar
• WellsGASheaBJO’ConnellDThe Newcastle–Ottawa Scale (NOS) for assessing the quality of non-randomized studies in meta-analysisAppl Eng Agric2000186727734
   Google Scholar
• TierneyJFStewartLAGhersiDBurdettSSydesMRPractical methods for incorporating summary time-to-event data into meta-analysisTrials2007811617555582
   PubMed Web of Science ®Google Scholar
• DerSimonianRMeta-analysis in the design and monitoring of clinical trialsStat Med1996151212491252
   Google Scholar
• VandenbrouckeJPBias in meta-analysis detected by a simple, graphical test. Experts’ views are still neededBMJ19983167129469470
   PubMed Web of Science ®Google Scholar
• StuckAERubensteinLZWielandDBias in meta-analysis detected by a simple, graphical test. Asymmetry detected in funnel plot was probably due to true heterogeneityBMJ19983167129469
   PubMed Web of Science ®Google Scholar
• DuvalSTweedieRTrim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysisBiometrics200056245546310877304
   PubMed Web of Science ®Google Scholar
• SchwarzerGMeta: an R package for meta-analysisR News2007374045
   Google Scholar
• ZinzaniPLGandolfiLBroccoliAMidtreatment 18F-fluorodeoxyglucose positron-emission tomography in aggressive non-Hodgkin lymphomaCancer201111751010101820960498
   PubMedGoogle Scholar
• YangDHMinJJSongHCPrognostic significance of interim 18F-FDG PET/CT after three or four cycles of R-CHOP chemotherapy in the treatment of diffuse large B-cell lymphomaEur J Cancer20114791312131821334197
   PubMed Web of Science ®Google Scholar
• YooCLeeDHKimJELimited role of interim PET/CT in patients with diffuse large B-cell lymphoma treated with R-CHOPAnn Hematol201190779780221181163
   PubMed Web of Science ®Google Scholar
• SpaepenKStroobantsSDupontPEarly restaging positron emission tomography with (18)F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin’s lymphomaAnn Oncol20021391356136312196360
   PubMed Web of Science ®Google Scholar
• SafarVDupuisJIttiEInterim [18F]fluorodeoxyglucose positron emission tomography scan in diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy plus rituximabJ Clin Oncol201230218419022162590
   PubMed Web of Science ®Google Scholar
• NolsNMounierNBouazzaSQuantitative and qualitative analysis of metabolic response at interim positron emission tomography scan combined with International Prognostic Index is highly predictive of outcome in diffuse large B-cell lymphomaLeuk Lymphoma201455477378023927393
   PubMed Web of Science ®Google Scholar
• HaiounCIttiERahmouniA[18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in aggressive lymphoma: an early prognostic tool for predicting patient outcomeBlood200510641376138115860666
   PubMed Web of Science ®Google Scholar
• CashenAFDehdashtiFLuoJHombASiegelBABartlettNL18F-FDG PET/CT for early response assessment in diffuse large B-cell lymphoma: poor predictive value of international harmonization project interpretationJ Nucl Med201152338639221321279
   PubMed Web of Science ®Google Scholar
• IttiEMeignanMBerriolo-RiedingerAAn international confirmatory study of the prognostic value of early PET/CT in diffuse large B-cell lymphoma: comparison between Deauville criteria and ΔSUVmaxEur J Nucl Med Mol Imaging20134091312132023649463
   PubMed Web of Science ®Google Scholar
• MamotCKlingbielDHitzFFinal results of a prospective evaluation of the predictive value of interim positron emission tomography in patients with diffuse large B-cell lymphoma treated with R-CHOP-14 (SAKK 38/07)J Clin Oncol201533232523252926150440
   PubMed Web of Science ®Google Scholar
• ChesonBDPfistnerBJuweidMEInternational Harmonization Project on LymphomaRevised response criteria for malignant lymphomaJ Clin Oncol200725557958617242396
   PubMed Web of Science ®Google Scholar
• ChesonBDThe International Harmonization Project for response criteria in lymphoma clinical trialsHematol Oncol Clin North Am200721584185417908623
   PubMed Web of Science ®Google Scholar
• ChesonBDHorningSJCoiffierBReport of an international workshop to standardize response criteria for non-Hodgkin’s lymphomas. NCI Sponsored International Working GroupJ Clin Oncol1999174124410561185
   PubMed Web of Science ®Google Scholar
• KostakogluLColemanMLeonardJPKujiIZoeHGoldsmithSJPET predicts prognosis after 1 cycle of chemotherapy in aggressive lymphoma and Hodgkin’s diseaseJ Nucl Med20024381018102712163626
   PubMed Web of Science ®Google Scholar
• DupuisJIttiERahmouniAResponse assessment after an inductive CHOP or CHOP-like regimen with or without rituximab in 103 patients with diffuse large B-cell lymphoma: integrating 18fluorodeoxyglucose positron emission tomography to the International Workshop CriteriaAnn Oncol200920350350719074215
   PubMed Web of Science ®Google Scholar
• HanHSEscalónMPHsiaoBSerafiniALossosISHigh incidence of false-positive PET scans in patients with aggressive non-Hodgkin’s lymphoma treated with rituximab-containing regimensAnn Oncol200920230931818842613
   PubMed Web of Science ®Google Scholar
• TerasawaTLauJBardetSFluorine-18-fluorodeoxyglucose positron emission tomography for interim response assessment of advanced-stage Hodgkin’s lymphoma and diffuse large B-cell lymphoma: a systematic reviewJ Clin Oncol200927111906191419273713
   PubMedGoogle Scholar
• IttiEJuweidMEHaiounCImprovement of early 18F-FDG PET interpretation in diffuse large B-cell lymphoma: importance of the reference backgroundJ Nucl Med201051121857186221078789
   PubMed Web of Science ®Google Scholar